RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM)
CUSIP: 76243J105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 67,341,788
- Total 13F shares
- 69,300,680
- Share change
- +1,307,107
- Total reported value
- $2,846,175,742
- Put/Call ratio
- 63%
- Price per share
- $41.06
- Number of holders
- 164
- Value change
- +$52,795,226
- Number of buys
- 85
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 76243J105?
CUSIP 76243J105 identifies RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76243J105:
Top shareholders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
12%
|
7,747,591
|
$335,703,118 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.7%
|
6,529,646
|
$282,929,562 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
9.5%
|
6,398,365
|
$277,241,155 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
7.9%
|
5,330,412
|
$230,966,752 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
7.6%
|
5,111,601
|
$221,485,671 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
3,304,146
|
$143,168,647 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.9%
|
3,268,579
|
$141,627,528 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
3,013,838
|
$130,589,601 | — | 31 Mar 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
4.3%
|
2,909,956
|
$126,088,393 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.3%
|
2,190,179
|
$94,900,456 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.5%
|
1,661,097
|
$71,975,333 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.3%
|
1,522,893
|
$65,986,954 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.2%
|
1,500,000
|
$64,995,000 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.8%
|
1,211,679
|
$52,502,051 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,180,705
|
$51,167,383 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.6%
|
1,050,000
|
$45,496,500 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
855,505
|
$37,069,032 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
1.2%
|
825,500
|
$35,768,915 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
1.1%
|
730,643
|
$31,658,761 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
704,842
|
$30,540,804 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.92%
|
621,427
|
$26,925,817 | — | 31 Mar 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.86%
|
577,000
|
$25,001,410 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.82%
|
550,000
|
$23,831,500 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.76%
|
515,000
|
$22,314,950 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
502,855
|
$21,788,707 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.72%
|
481,533
|
$20,865,000 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
473,455
|
$20,514,805 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
406,745
|
$17,624,261 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.55%
|
367,517
|
$14,384,615 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.42%
|
285,651
|
$12,377,258 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.42%
|
281,157
|
$12,182,000 | — | 31 Mar 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.4%
|
271,421
|
$11,760,672 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.33%
|
220,905
|
$9,571,814 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.32%
|
218,657
|
$9,474,408 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
206,980
|
$8,968,444 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.29%
|
193,523
|
$8,385,352 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.28%
|
190,520
|
$8,255,232 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
183,776
|
$7,963,014 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
182,870
|
$7,923,759 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
172,752
|
$7,485,344 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.26%
|
172,647
|
$7,480,795 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.26%
|
172,207
|
$7,461,729 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
171,565
|
$7,433,911 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
167,838
|
$7,272,422 | — | 31 Mar 2024 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.22%
|
145,291
|
$6,295,459 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
142,735
|
$6,184,708 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
127,536
|
$5,526,135 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.19%
|
125,000
|
$5,416,250 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
111,114
|
$4,814,569 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.16%
|
108,755
|
$4,712,354 | — | 31 Mar 2024 |
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) as of Q2 2024
As of 30 Jun 2024,
RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,300,680 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, NEA Management Company, LLC, Frazier Life Sciences Management, L.P., and STATE STREET CORP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
166
Q2 2024 holders
164
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.